Cite
HARVARD Citation
Hammel, P. et al. (n.d.). P-098TRYbeCA-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441). Annals of oncology. p. . [Online].